TITLE
The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy

ORGANISM
Homo sapiens

SUMMARY
Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature

DESIGN
136 breast cancer samples that were treated with tamoxifen were classified using the 76-gene signature

PLATFORM
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
18821012

